ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.34
+0.01 (0.19%)
At close: Aug 28, 2026, 4:00 PM EDT
5.33
-0.01 (-0.19%)
After-hours: Aug 28, 2026, 4:10 PM EDT
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $60.62 million as of August 28, 2026. Its market cap has decreased by -60.26% in one year.
Market Cap
60.62M
Enterprise Value
-73.62M
1-Year Change
-60.26%
Ranking
Category
Stock Price
$5.34
ChartMarket Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $183.04M to $60.62M, a decrease of -66.88%. That is a compound annual growth rate of -63.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 60.62M | -21.43% |
| Dec 31, 2025 | 77.15M | -57.85% |
| Jul 28, 2025 | 183.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| INmune Bio | 64.67M |
| Boundless Bio | 64.37M |
| Alps Group | 64.05M |
| BioStem Technologies | 63.01M |
| Serina Therapeutics | 62.49M |
| Edesa Biotech | 62.42M |
| Heron Therapeutics | 62.01M |
| Eloxx Pharmaceuticals | 60.83M |